References
- Blue R, Chancellor J, Suresh R, Carnell L, Reyes D, Nowadly C, Antonsen E. 2017. Challenges in clinical management of radiation-induced illnesses. IN: Exploration Spaceflight; [accessed 2020 Sep 16]. https://ntrs.nasa.gov/search.jsp?R=20170009925_2019-04-26T15:52:06+00:00Z.
- Chernyshenko V, Snezhkova E, Mazur M, Chernyshenko T, Platonova T, Sydorenko O, Lugovskoy E, Nikolaev V. 2019. Blood coagulation parameters in rats with acute radiation syndrome receiving activated carbon as a preventative remedy. UkrBiochemJ. 91(2):52–62.
- Esker J, Moyer B, Raulli RE, Grace M. 2015. Development of a large animal model of H-ARS in minipigs: natural history and biomarker results for radiation injury from multiple institutions using a harmonized model. 61st Annual Meeting of the Radiation Research Society; Weston FL.
- Fleming TR, Harrington DP. 1984. Estimation of the survival distribution in censored data. Comm in Stats Theory Methods 13:2469–2486.
- Gando S. 2010. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med. 38(2 Suppl):S35–S42.
- Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE. 2009. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 75(1):156–163.
- Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, et al. 2008. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability. Int J Radiat Oncol Biol Phys. 71(5):1372–1380.
- Moroni M, Coolbaugh TV, Lombardini E, Mitchell JM, Moccia KD, Shelton LJ, Nagy V, Whitnall MH. 2011. Hematopoietic radiation syndrome in the Gottingen minipig. Radiat Res. 176(1):89–101.
- National Research Council (NRC). 2011. Guide for the care and use of laboratory animals. 8th Ed. Washington (DC): National Academies Press.
- Ohkita T. 1975. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors, Part II: biological effects; A: acute effects. J Radiat Res. 16(supplement):49–66.
- Olsen AK, Hansen AK, Jespersen J, Marckmann P, Bladbjerg EM. 1999. The pig as a model in blood coagulation and fibrinolysis research. Scand J Lab Anim Sci. 26:214–224.
- Pliszczak-Krol A, Rzasa A, Gemra M, Krol J, Luczak G, Zyzak A, Zalewski D, Iwaszko-Simonik A, Graczyk S. 2016. Age-related changes of platelet and plasma coagulation parameters in young pigs. J Vet Diag Invest. 28(5):561–567.
- Robins HI, Won M, Seiferheld WF, Schultz CJ, Choucair AK, Brachman DG, Demas WF, Mehta MP. 2006. Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021. Neuro-Oncology. 8(1):47–52.
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352(10):987–996.
- Venkatesulu BP, Mahadevan LS, Aliru ML, Yang X, Bodd MH, Singh PK, Yusuf SW, Abe J, Krishnan S. 2018. Radiation-induced endothelial vascular injury: a review of possible mechanisms. J Am Coll Cardiol Basic Trans Sci. 3(4):563–572.
- Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, et al. 2004. Medical management of the acute radiation syndrome: recommendations of the strategic national stockpile radiation working group. Ann Intern Med. 140(12):1037–1051.
- Weintraub NL, Jones WK, Manka D. 2010. Understanding radiation-induced vascular disease. J Am Coll Cardiol. 55(12):1237–1239.